Tamoxifen and bone morphogenic protein-7 modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats
Abstract Background Peritoneal fibrosis (PF) represents a long-term complication of peritoneal dialysis (PD), affecting peritoneal membrane (PM) integrity and function. Understanding the mechanisms underlying PF development in an uremic environment aiming alternative therapeutic strategies for treat...
Main Authors: | Filipe M. O. Silva, Elerson C. Costalonga, Cleonice Silva, Ana C. O. Carreira, Samirah A. Gomes, Mari C. Sogayar, Camilla Fanelli, Irene L. Noronha |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | Molecular Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s10020-019-0110-5 |
Similar Items
-
Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil
by: Kurata T, et al.
Published: (2018-08-01) -
10-year-long survival in a PD patient with severe calcifying encapsulating peritoneal sclerosis treated with tamoxifen: a case-report
by: Vassilios Liakopoulos, et al.
Published: (2020-03-01) -
Peritoneal Dialysis Vintage and Glucose Exposure but Not Peritonitis Episodes Drive Peritoneal Membrane Transformation During the First Years of PD
by: Maria Bartosova, et al.
Published: (2019-04-01) -
Saikosaponin D Inhibits Peritoneal Fibrosis in Rats With Renal Failure by Regulation of TGFβ1/ BMP7 / Gremlin1/ Smad Pathway
by: Liu Ruiqi, et al.
Published: (2021-10-01) -
Peritoneal fibrosis
by: Horacio Alfredo Trevisani
Published: (2017-04-01)